DRUG · Mapped RxNorm record
metformin
Normalized identity: metforminView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)
NCT02019979
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BEHAVIORAL · Unmapped registry intervention
carbohydrate restricted diet
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedMetformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Non-small Cell Lung Cancer Stage IIIB/IVunresolved
Non-small Cell Lung Cancer Metastaticunresolved
Interventions
metforminDRUG · verified · RxNorm: metformin
carbohydrate restricted dietBEHAVIORAL
Sponsors & collaborators
Beth Israel Medical Centerlead sponsor
St. Luke's-Roosevelt Hospital Centercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02019979 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.